Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacokinetic Study of Tacrolimus and Mycophenolate Mofetil in Kidney Transplant Recipients With Hyperkalemia Receiving Patiromer

Trial Profile

Pharmacokinetic Study of Tacrolimus and Mycophenolate Mofetil in Kidney Transplant Recipients With Hyperkalemia Receiving Patiromer

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 18 Oct 2018

At a glance

  • Drugs Patiromer (Primary) ; Mycophenolate mofetil; Tacrolimus
  • Indications Hyperkalaemia
  • Focus Pharmacokinetics
  • Most Recent Events

    • 09 Oct 2018 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.
    • 09 Oct 2018 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019.
    • 26 Sep 2017 Planned End Date changed from 1 Jan 2019 to 1 Dec 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top